NCLA Sues CPSC Over Unsubstantiated Baby Sleep Product Warnings

Event summary

  • NCLA filed a lawsuit in D.C. District Court seeking summary judgment to force CPSC to retract its warning against weighted infant sleep products.
  • CPSC’s warning, issued without adequate research, has pushed Dreamland Baby to the brink of bankruptcy.
  • Congress passed a law requiring CPSC to provide accurate, non-misleading explanations for product safety claims.
  • CPSC’s decision relied on CDC and NIH recommendations, which were based on a third-party advocacy group’s findings.

The big picture

The lawsuit highlights the tension between regulatory agencies and businesses, particularly in industries where product safety is a concern. CPSC’s actions, if upheld, could lead to broader implications for how agencies issue warnings and the legal standards they must meet. The case also underscores the potential financial impact on small businesses operating in highly regulated markets.

What we're watching

Regulatory Overreach
Whether CPSC’s actions will set a precedent for other agencies issuing warnings without sufficient evidence.
Legal Precedent
How the court’s decision may impact future challenges to administrative agency actions under the APA.
Market Disruption
The pace at which other companies in the infant sleep product sector may face similar regulatory scrutiny.